Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-07-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849706336149831680 |
|---|---|
| author | Sara Bringhen Lorenzo Cani Nicola Giuliani Silvia Mangiacavalli Giulia Benevolo Elisabetta Antonioli Renato Zambello Roberto Ria Iolanda Donatella Vincelli Sonia Ronconi Sonia More Antonietta Pia Falcone Alessandro Allegra Mattia D'Agostino Andrea Evangelista Andrea Capra Elisa Sciorsci Paola Curci Patrizia Tosi Anna Marina Liberati Anna Maria Cafro Angelo Belotti Francesca Patriarca Donato Mannina Katia Mancuso Francesco Cattel Giovannino Ciccone Benedetto Bruno Mario Boccadoro Alessandra Larocca |
| author_facet | Sara Bringhen Lorenzo Cani Nicola Giuliani Silvia Mangiacavalli Giulia Benevolo Elisabetta Antonioli Renato Zambello Roberto Ria Iolanda Donatella Vincelli Sonia Ronconi Sonia More Antonietta Pia Falcone Alessandro Allegra Mattia D'Agostino Andrea Evangelista Andrea Capra Elisa Sciorsci Paola Curci Patrizia Tosi Anna Marina Liberati Anna Maria Cafro Angelo Belotti Francesca Patriarca Donato Mannina Katia Mancuso Francesco Cattel Giovannino Ciccone Benedetto Bruno Mario Boccadoro Alessandra Larocca |
| author_sort | Sara Bringhen |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-9debd2d83db24d7692deca227c44aad5 |
| institution | DOAJ |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-9debd2d83db24d7692deca227c44aad52025-08-20T03:16:14ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-07-01999110.3324/haematol.2025.287510Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trialSara Bringhen0Lorenzo Cani1Nicola Giuliani2Silvia Mangiacavalli3Giulia Benevolo4Elisabetta Antonioli5Renato Zambello6Roberto Ria7Iolanda Donatella Vincelli8Sonia Ronconi9Sonia More10Antonietta Pia Falcone11Alessandro Allegra12Mattia D'Agostino13Andrea Evangelista14Andrea Capra15Elisa Sciorsci16Paola Curci17Patrizia Tosi18Anna Marina Liberati19Anna Maria Cafro20Angelo Belotti21Francesca Patriarca22Donato Mannina23Katia Mancuso24Francesco Cattel25Giovannino Ciccone26Benedetto Bruno27Mario Boccadoro28Alessandra Larocca29SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Department of Oncology, AOU Citta della Salute e della Scienza di Torino, University of Torino, TorinoDivision of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, TorinoUniversity of Parma & AOU Parma, ParmaDivision of Hematology, IRCCS Fondazione Policlinico San Matteo, PaviaSSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Department of Oncology, AOU Citta della Salute e della Scienza di Torino, University of Torino, TorinoHematology Unit, AOU Careggi, FlorenceDepartment of Medicine (DIMED), Hematology, Padua University, PaduaUniversity of Bari Aldo Moro Medical School, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), BariDivisione di Ematologia, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio CalabriaIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", MeldolaAOU delle Marche, Universita Politecnica delle Marche, AnconaHematology, IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni RotondoDivision of Hematology, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, MessinaDivision of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, TorinoUnit of Clinical Epidemiology, AOU Citta della Salute e della Scienza di Torino and CPO Piemonte, TorinoEuropean Myeloma Network (EMN)SC Farmacia Ospedaliera, AOU Citta della Salute e della Scienza di Torino, TorinoHematology and Stem Cell Transplantation Unit, AOU Consorziale Policlinico, BariUO Ematologia, Ospedale di Rimini, RiminiA.O. Santa Maria di Terni – Universita degli Studi di Perugia, Terni–PerugiaSC Ematologia, GOM Niguarda, MilanoDepartment of Hematology, ASST Spedali Civili di Brescia, BresciaHematologic Clinic and Transplant Center, University Hospital of Central Friuli, DMED, University of Udine, UdineOncology-Hematology Department, Papardo Hospital, MessinaIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”, Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Universita di Bologna, BolognaSC Farmacia Ospedaliera, AOU Citta della Salute e della Scienza di Torino, TorinoUnit of Clinical Epidemiology, AOU Citta della Salute e della Scienza di Torino and CPO Piemonte, TorinoDivision of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, TorinoEuropean Myeloma Network (EMN), Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, TorinoDivision of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino Not available. https://haematologica.org/article/view/12194 |
| spellingShingle | Sara Bringhen Lorenzo Cani Nicola Giuliani Silvia Mangiacavalli Giulia Benevolo Elisabetta Antonioli Renato Zambello Roberto Ria Iolanda Donatella Vincelli Sonia Ronconi Sonia More Antonietta Pia Falcone Alessandro Allegra Mattia D'Agostino Andrea Evangelista Andrea Capra Elisa Sciorsci Paola Curci Patrizia Tosi Anna Marina Liberati Anna Maria Cafro Angelo Belotti Francesca Patriarca Donato Mannina Katia Mancuso Francesco Cattel Giovannino Ciccone Benedetto Bruno Mario Boccadoro Alessandra Larocca Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial Haematologica |
| title | Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial |
| title_full | Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial |
| title_fullStr | Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial |
| title_full_unstemmed | Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial |
| title_short | Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial |
| title_sort | bortezomib melphalan prednisone versus lenalidomide dexamethasone in elderly patients with multiple myeloma the real mm phase iv trial |
| url | https://haematologica.org/article/view/12194 |
| work_keys_str_mv | AT sarabringhen bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT lorenzocani bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT nicolagiuliani bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT silviamangiacavalli bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT giuliabenevolo bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT elisabettaantonioli bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT renatozambello bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT robertoria bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT iolandadonatellavincelli bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT soniaronconi bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT soniamore bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT antoniettapiafalcone bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT alessandroallegra bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT mattiadagostino bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT andreaevangelista bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT andreacapra bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT elisasciorsci bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT paolacurci bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT patriziatosi bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT annamarinaliberati bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT annamariacafro bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT angelobelotti bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT francescapatriarca bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT donatomannina bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT katiamancuso bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT francescocattel bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT giovanninociccone bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT benedettobruno bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT marioboccadoro bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial AT alessandralarocca bortezomibmelphalanprednisoneversuslenalidomidedexamethasoneinelderlypatientswithmultiplemyelomatherealmmphaseivtrial |